Table 2.
Available maternal health outcomes
| Trial name | LIMIT [55–57] | UPBEAT [58] | ROLO [59] | LiP [60–63] | Belgian Flanders [64] | NELLI [65] | The TOP study [66] |
|---|---|---|---|---|---|---|---|
| Investigators | Dodd, Grivell, Owens | Poston | McAuliffe | Vinter, Tanvig, Jensen | Bogaerts, Devlieger | Luoto | Renault |
| Timing assessment | 3 years | 3 years | 5 years | 4–7 years | 5–7 years | 3 years | |
| Height | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Weight | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Weight change | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| BMI | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Circumferences | |||||||
| -Neck | ✓ | ||||||
| -Waist | ✓ | ✓ | |||||
| -Hip | ✓ | ||||||
| -Thigh | ✓ | ||||||
| -Mid upper arm | ✓ | ||||||
| -Wrist | ✓ | ||||||
| SFTM | |||||||
| -Subscapular | ✓ | ✓ | |||||
| -Triceps | ✓ | ✓ | |||||
| -Biceps | ✓ | ✓ | |||||
| -Suprailiac | ✓ | ✓ | |||||
| % Body fat | ✓ | ✓ | |||||
| DXA | ✓ Subset | ||||||
| Bodpod | ✓ | ||||||
| BIA | ✓ | ✓ | |||||
| Dietary intake | ✓ Also 6 months, 18 months | ✓ | ✓ | ✓ | |||
| Physical activity | ✓ Also 6 months, 18 months | ✓ | ✓ | ✓ | |||
| Metabolic syndrome | ✓ | ✓ | ✓ | ||||
| Glucose intolerance | ✓ Subset | ✓ | ✓ | ✓ | At 12 months postpartum | ||
| Insulin | ✓ | ||||||
| Type 2 DM | ✓ Subset | ✓ | ✓ Self report | ✓ Fasting glucose | ✓ | ||
| Hypertension/BP | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Hyperlipidaemia | ✓ | ✓ | ✓ | ||||
| Inflammatory markers | ✓ | ✓ | |||||
| Transferrin??? | ✓ | ||||||
| DNA | ✓ Saliva | ✓ | |||||
| RNA | ✓ | ||||||
| Anxiety | ✓ Also 6 months, 18 months | ✓ | |||||
| Anxiety-eating | ✓ TFEQ | ✓ | |||||
| Depression | ✓ Also 6 months, 18 months | ✓ | ✓ | ✓ | |||
| Quality of life | ✓ Also 6 months, 18 months | ✓ | ✓ | ✓ | |||
| Health | ✓ | ✓ | ✓ | ✓ | |||
| Reproductive health history | ✓ | ✓ | ✓ | ✓ | ✓ | ||
| Life events | ✓ | ✓ | |||||